Rasna Therapeutics, Inc. (OTC:RASP)
Industry: Technology

Rasna Therapeutics, Inc., a biotechnology company, engages in developing targeted drugs to treat diseases in oncology and immunology, primarily focusing on the treatment of leukemia. It is involved in modulating the molecular targets NPM1 and LSD1, which are implicated in the disease progression of leukemia and lymphoma. The company is developing RASP-101, a formulated dactinomycin product to enable multi-center clinical studies in patients with NPMI-mutated acute myelogenous leukemia. Rasna Therapeutics, Inc. was founded in 2013 and is headquartered in New York, New York.

Current Quote*
Last: $0.249
Change: 0.097
Book: $4.980
Volume: 106,700

As Of: 10/30 17:24 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol RASP

  • No BuyIns.Net Alerts Available for RASP

Graphs for RASP


3 Month Graph


6 Month Graph


1 Year Graph